Dutka D P, Donnelly J E, Nihoyannopoulos P, Oakley C M, Nunez D J
National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
Heart. 1999 Feb;81(2):141-7. doi: 10.1136/hrt.81.2.141.
To document the cardiac phenotype associated with Friedreich's ataxia, a recessively inherited disorder characterised by spinocerebellar degeneration.
Individuals with Friedreich's ataxia who accepted the invitation to participate in the study.
The cardiomyopathy associated with Friedreich's ataxia may offer a human model for the study of factors modulating cardiac hypertrophy.
55 patients (mean (SD) age 30 (9) years) with a clinical diagnosis of Friedreich's ataxia were studied by clinical examination, electrocardiography, cross sectional and Doppler echocardiography, and analysis of the GAA repeat in the first intron of the frataxin gene.
A wide variety of cardiac morphology was documented. Subjects with normal frataxin alleles had no evidence of cardiomyopathy. In homozygous subjects, a relation was found between the thickness of the interventricular septum (r = 0.53, p < 0.005), left ventricular mass (r = 0.48, p < 0.01), and the number of GAA repeats on the smaller allele of the frataxin gene. No relation was shown between the presence of electrocardiographic abnormalities (mainly repolarisation changes) and either the pattern of ventricular hypertrophy (if present) and degree of neurological disability or the length of time since diagnosis. No tendency to ventricular thinning or dilatation with age was found. Although ventricular systolic function appeared impaired in some cases, Doppler studies of ventricular filling were within the normal range for age.
The cardiomyopathy associated with Friedreich's ataxia shows a variable phenotype which is not concordant with the presence of ECG abnormalities or the neurological features of the condition. As the genetic basis for Friedreich's ataxia has been established, further studies will help to clarify the molecular mechanisms of the cardiac hypertrophy.
记录与弗里德赖希共济失调相关的心脏表型,这是一种以脊髓小脑变性为特征的隐性遗传性疾病。
接受邀请参与本研究的弗里德赖希共济失调患者。
与弗里德赖希共济失调相关的心肌病可能为研究调节心脏肥大的因素提供一个人类模型。
对55例临床诊断为弗里德赖希共济失调的患者(平均(标准差)年龄30(9)岁)进行临床检查、心电图检查、横断面和多普勒超声心动图检查,并分析铁转运蛋白基因第一内含子中的GAA重复序列。
记录到多种心脏形态。具有正常铁转运蛋白等位基因的受试者没有心肌病的证据。在纯合子受试者中,发现室间隔厚度(r = 0.53,p < 0.005)、左心室质量(r = 0.48,p < 0.01)与铁转运蛋白基因较小等位基因上的GAA重复序列数量之间存在关联。心电图异常(主要是复极改变)的存在与心室肥厚模式(如果存在)、神经功能障碍程度或诊断后的时间长度之间均未显示出关联。未发现随年龄增长心室变薄或扩张的趋势。虽然在某些情况下心室收缩功能似乎受损,但心室充盈的多普勒研究结果在年龄正常范围内。
与弗里德赖希共济失调相关的心肌病表现出可变的表型,与心电图异常的存在或该疾病的神经学特征不一致。由于弗里德赖希共济失调的遗传基础已经确立,进一步的研究将有助于阐明心脏肥大的分子机制。